Equity Capital Markets

Protagonist Therapeutics, Inc.

04/23
|
$100.0 Million
Protagonist
Piper Sandler served as bookrunner for Protagonist Therapeutics, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sector
Healthcare
Sub-Sector
Biopharma

Related Transactions

All Transactions
$30.0 Million
milestone
Milestone Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$172.4 Million
Praxis
Praxis Precision Medicines
Confidentially Marketed Follow-On Offering
Active Bookrunner
$150.0 Million
Catalyst
Catalyst Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$161.0 Million
Keros
Keros Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
$410.0 Million
NB
The Needham Bank
Initial Public Offering
Sole Marketing Agent
$115.1 Million
Ocular
Ocular Therapeutix, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$747.5 Million
Merit
Merit Medical Systems, Inc.
Convertible Offering
Active Bookrunner
$632.9 Million
Super
Super Micro Computer, Inc.
COnfidentially Marketed Follow-On Offering
Passive Bookrunner
$175.3 Million
Skyward
Skyward Specialty Insurance
Follow-On Offering
Active Bookrunner
$733.6 Million
CCC
CCC Intelligent Solutions Holdings Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$300.0 Million
Navalent
Nuvalent, Inc.
Follow-On Offering
Active Bookrunner
Scholar
Scholar Rock Holding Corporation
Confidentially Marketed Follow-On Offering
Active Bookrunner
$1.5 Billion
Birkenstock
Birkenstock Holding plc
Initial Public Offering
Co-Manager
$63.2 Million
ALX
ALX Oncology
Confidentially Marketed Follow-On Offering
Active Bookrunner
$258.7 Million
Biohaven Ltd.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$499.9 Million
Magrigal
Madrigal Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner

© 2024 Piper Sandler Companies. Since 1895. All rights reserved.